Graham Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Sell
4,394
-775
-15% -$161K 0.02% 484
2026
Q1
$1.09M Buy
+5,169
New +$1.11M 0.03% 414
2025
Q1
Sell
-3,197
Closed -$378K 1314
2024
Q4
$378K Sell
3,197
-2,545
-44% -$297K 0.01% 839
2024
Q3
$635K Buy
5,742
+3,271
+132% +$342K 0.01% 574
2024
Q2
$243K Buy
+2,471
New +$252K 0.01% 794
2024
Q1
Sell
-2,872
Closed -$289K 1078
2023
Q4
$289K Buy
+2,872
New +$285K 0.01% 741
2023
Q1
Sell
-11,479
Closed -$882K 1075
2022
Q4
$882K Buy
+11,479
New +$872K 0.03% 578
2022
Q3
Sell
-37,691
Closed -$1.97M 1079
2022
Q2
$1.97M Buy
+37,691
New +$2.14M 0.08% 211

Other funds holding CAH

Graham Capital Management's CAH Position: Q2 2026 in Review

Graham Capital Management reduced its Cardinal Health (CAH) stake by 15% in Q2 2026, selling an estimated $161K and leaving 4,394 shares worth $1.04M. The position accounts for 0.02% of the portfolio, ranked #484.

Graham Capital Management first reported a position in CAH in Q2 2022 and has held it in 8 quarters since. The position peaked at $1.97M in Q2 2022. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Graham Capital Management held 4,394 shares of Cardinal Health worth $1.04M as of Q2 2026.
  • Graham Capital Management sold 775 Cardinal Health shares in Q2 2026, an estimated $161K.
  • Cardinal Health made up 0.02% of Graham Capital Management's portfolio in Q2 2026, its #484 holding.
  • Graham Capital Management first reported a position in Cardinal Health in Q2 2022 and has held it in 8 quarters since.
  • Graham Capital Management's Cardinal Health position peaked at $1.97M in Q2 2022.
  • 1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.